Articles from Daniel Houle, Concerned Stockholder of Vaxart, Inc.

Believe Elevating W. Mark Watson – who Received only 56% of Votes Cast at Last Annual Meeting – to Lead Independent Director Fails to Deliver Real Reform

Question Board’s Repeated Delay Tactics and Demand Transparency on Voting Results, Nasdaq Compliance and Governance Changes

Oppose Management’s Latest Attempt to Push Through Proposal Despite Prior Overwhelming Stockholder Opposition

Urge Stockholders to Vote “AGAINST” Reverse Stock Split at Upcoming Special Meeting